HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.

AbstractBACKGROUND:
It is unclear if the category of acute rejection with intimal arteritis (ARV) is relevant to short- and long-term clinical outcomes and if the graft outcomes are affected by the severity of intimal arteritis.
METHODS:
One hundred forty-eight ARV episodes were reviewed and categorized according to the 2013 Banff criteria of AMR: T cell-mediated rejection with intimal arteritis (v) lesion (TCMRV; n = 78), total antibody-mediated rejection with v lesion (AMRV), which were further divided into suspicious AMRV (n = 37) and AMRV (n = 33). The Banff scores of intimal arteritis (v1, v2 and v3) represented low, moderate, and high ARV severity.
RESULTS:
The grafts with TCMRV, suspicious AMRV (sAMRV), and AMRV showed similar responses to antirejection therapy, whereas the grafts with v2- or v3-ARV responded significantly poorer compared to those with v1-ARV. The 8-year death-censored graft survival (DCGS) rate was 56.8% of TCMRV versus 34.1% of total AMRV (Log rank, P = 0.03), but the 1- and 5-year DCGS rates were comparable between the 2 groups; moreover, the 1-, 5-, and 8-year DCGS rates of v1-ARV were evidently higher than v2- and v3-ARV (each pairwise comparison to v1-AVR yields P < 0.01); in contrast, the DCGS rates were similar between sAMRV and AMRV. The existing donor-specific antibodies or moderate microvascular inflammation or C4d-positive staining or intensive tubulointerstitial inflammation played a less significant role on the long-term graft survival.
CONCLUSIONS:
Compared to the category, the ARV severity is more closely associated with the initial response to antirejection therapy and long-term graft failure. The sAMRV and AMRV might represent a spectrum of the same disorder.
AuthorsKaiyin Wu, Klemens Budde, Danilo Schmidt, Hans-Helmut Neumayer, Birgit Rudolph
JournalTransplantation (Transplantation) Vol. 99 Issue 8 Pg. e105-14 (Aug 2015) ISSN: 1534-6080 [Electronic] United States
PMID25719260 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers
  • Immunosuppressive Agents
  • Isoantibodies
  • Peptide Fragments
  • Complement C4b
  • complement C4d
Topics
  • Acute Disease
  • Adult
  • Aged
  • Arteritis (diagnosis, drug therapy, immunology, pathology)
  • Biomarkers (blood)
  • Biopsy
  • Complement C4b (metabolism)
  • Female
  • Graft Rejection (diagnosis, drug therapy, immunology, pathology)
  • Graft Survival
  • Humans
  • Immunity, Cellular
  • Immunity, Humoral
  • Immunosuppressive Agents (therapeutic use)
  • Isoantibodies (blood)
  • Kidney (immunology, pathology, physiopathology)
  • Kidney Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Peptide Fragments (metabolism)
  • Predictive Value of Tests
  • Retrospective Studies
  • T-Lymphocytes (immunology)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: